Latest Bacillus anthracis Stories
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.
ANNAPOLIS, Md., Sept. 3 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
Research published by Army scientists indicates that a minor reduction in levels of one particular gene, known as CD45, can provide protection against two divergent microbes: the virus that causes Ebola hemorrhagic fever and the bacterium that causes anthrax
ROCKVILLE, Md., July 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc.
ANNAPOLIS, Md., June 2 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
ANNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ --PharmAthene, Inc.
Scientists are suggesting that the deadly bacteria anthrax has ancient links to North America.
ANNAPOLIS, Md., Feb. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
PRINCETON, N.J. and ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. , a leading monoclonal antibody company, and PharmAthene, Inc.
Americans became fearful of anthrax in October of 2001, after the white powder killed five people and sickened 17 as it was sent in envelopes through the U.S. postal service.
Bacillus anthracis is a Gram-positive spore-forming, rod-shaped bacterium, with a width of 1-1.2Âµm and a length of 3-5Âµm. It can grow in aerobic or anaerobic conditions. It is the only known bacterium to synthesize a protein capsule and the only pathogenic bacterium to carry its own adenylyl cyclase virulence factor. They form oval spores located centrally in a non-swollen sporangium. These spores are highly resilient and can survive extreme temperatures, low-nutrient environments, and...
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).